Combined with a low pancreatic expression of CCK-1 receptor mRNA, acceptable acute in vivo tolerability and lack of histopathological signs of pancreatitis after a single, high dose of NN9056 in lean LYD pigs, this confirmed the pig as a relevant model for evaluation of pharmacodynamic effects of CCK analogues. The gene discussed is CCK; the disease is pancreatitis.